LipocineLPCN

13F holders, Q2 2026 (June 30)
36holders −11
4new positions
15sold out
2famous investors
$2.56avg. 13F price*

At the end of Q2 2026, 36 institutions reported holding Lipocine Inc. (LPCN) in their 13F filings, down 11 from Q1 2026. 4 opened new positions and 15 sold out. The largest holders were Squadron Capital Management LLC ($2.1M), Ikarian Capital, LLC ($1.3M) and Eversept Partners, LP ($755K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Lipocine Inc.
CUSIP
53630X203
Latest filing quarter
Q2 2026

History

Number of 13F holders

01020304050 Q1 2024: 18Q1 2024Q2 2024: 19Q2 2024Q3 2024: 18Q3 2024Q4 2024: 17Q4 2024Q1 2025: 19Q1 2025Q2 2025: 18Q2 2025Q3 2025: 22Q3 2025Q4 2025: 26Q4 2025Q1 2026: 47Q1 2026Q2 2026: 36Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions4$589K
Exits15$7.0M

All 13F filers, Q1 2026 → Q2 2026: 885,025 shares bought and 1,022,999 shares sold, net −137,974 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 36 holders

Squadron Capital Management LLC 0.71% Add +80.0% 810,000 $2.1M
Ikarian Capital, LLC 0.21% No change 508,556 $1.3M
Eversept Partners, LP 0.04% No change 294,989 $755K
Vanguard Capital Management LLC 0.00% Add +15.0% 230,823 $591K
Acadian Asset Management LLC 0.00% New 170,417 $435K
Boothbay Fund Management, LLC 0.01% No change 140,487 $360K
Jane Street Group, LLC 0.00% Add +375.5% 95,227 $244K
BlackRock, Inc. 0.00% No change 89,272 $229K
Two Sigma Investments, LP 0.00% Add +151.5% 84,887 $217K
Citadel Advisors 0.00% Add +179.2% 81,221 $208K
Seven Fleet Capital Management LP 0.03% Reduce -36.9% 78,842 $202K
Geode Capital Management, LLC 0.00% Add +18.0% 74,477 $191K
Renaissance Technologies 0.00% Add +79.8% 69,209 $177K
Vanguard Fiduciary Trust Co. 0.00% Add +68.3% 54,539 $140K
Dimensional Fund Advisors LP 0.00% Add +92.3% 36,775 $94K
HRT Financial LP 0.00% New 29,238 $74K
Susquehanna International Group, LLP 0.00% Add +1.9% 25,376 $65K
State Street Corp. 0.00% No change 22,407 $57K
Gsa Capital Partners LLP 0.00% New 18,666 $48K
Birchview Capital, LP 0.02% Reduce -85.0% 16,712 $43K
Northern Trust Corp. 0.00% Add +22.2% 15,942 $41K
T. Rowe Price Associates Inc. 0.00% New 12,266 $32K
Barclays PLC 0.00% Add +4.4% 9,827 $25K
UBS Group AG 0.00% Add +2.9% 3,596 $9K
Wells Fargo & Company 0.00% No change 2,706 $7K
Vanguard Global Advisers, LLC 0.00% No change 1,691 $4K
Tower Research Capital LLC (TRC) 0.00% Reduce -27.3% 678 $2K
Morgan Stanley 0.00% No change 574 $1K
Caldwell Sutter Capital, Inc. 0.00% No change 471 $1K
Osaic Holdings, Inc. 0.00% Add +66.4% 238 $609
Group One Trading LLC 0.00% No change 132 $338
PlanVest Financial, Inc 0.00% No change 111 $284
SBI Securities Co., Ltd. 0.00% No change 67 $172
Tidemark, LLC 0.00% No change 59 $151
Bogart Wealth, LLC 0.00% No change 3 $8
Farther Finance Advisors, LLC 0.00% No change 1 $3

"% of holder's portfolio" is LPCN's weight in each manager's 13F, not the share of Lipocine Inc. the manager owns.